Results 161 to 170 of about 1,056 (174)

Nemolizumab decreases lesions and itch in prurigo nodularis

Medicom Conference Report AAD 2023, 2023
Shawn Kwatra, Susanne Kammerer
openaire   +1 more source

Nemolizumab gegen Neurodermitis

Aktuelle Dermatologie, 2017
openaire   +1 more source

Nemolizumab‐induced exacerbation of atopic dermatitis

The Journal of Dermatology
Hirofumi Kamada, Nobuyuki Arakawa, Marino Kato, Takayuki Tanji, Daisuke Watabe, Naoki Yanagawa, Hiroo Amano   +6 more
openaire   +2 more sources

Dupilumab/nemolizumab/upadacitinib

Reactions Weekly
openaire   +1 more source

A case of bullous pemphigoid after nemolizumab administration

The Journal of Dermatology
Yuriko Ishikawa, Ken Washio
openaire   +2 more sources

Nemolizumab to target the itch–scratch cycle in paediatric atopic dermatitis

British Journal of Dermatology, 2023
openaire   +2 more sources

Characteristics of suitable cases for treatment with nemolizumab based on clinical findings and cutaneous adverse events

Journal of Dermatology
Akiko Sugiyama
exaly  

Nemolizumab Improves Pruritus in Patients With Intrinsic Atopic Dermatitis Lacking Atopic Predisposition: A Single‐Centre Pilot Retrospective Cohort Study

Experimental Dermatology
Keita Tsutsui, Shinichi Imafuku, Emi Sato   +2 more
exaly  

Nemolizumab reduziert Juckreiz bei Atopischer Dermatitis

Aktuelle Dermatologie, 2017
openaire   +1 more source

Pre‐ and Postnatal Development Study of Nemolizumab, a Humanized Anti‐Interleukin‐31 Receptor A Monoclonal Antibody, in Cynomolgus Monkey

Birth Defects Research
Ryuichi Katagiri
exaly